another tpac ch 11 snippet
...
“Stop looking up KVM switches, Korv—my setup is fine.”
“It’s for me,” Korvin insists. When no one believes him, he amends, “And it could be for you too, Barbie.”
“You don’t need that kind of setup,” Dick absently calls out as he enters the room, holding a couple of documents and envelopes under his arm.
Korvin ignores him. “Just thinkin’ it’d be really convenient: less of a rat’s nest, multiple interface points, rack mounting—”
“—I do not want to see you raccooning around my cables,” Babs says firmly. “Appreciate it, but no.”
Korvin’s mouth twists into a petulant scowl as he turns back to his assigned reading; Gotham Academy is reopening their campus for the spring. Tim’s due back in his dorm end of next week—meaning he’s supposed to be home for his dad to drop him off the day before—but he finds his motivation for school has reached an all-time low.
“Korvin Kwan—what the hell?!” Dick’s indignant question interrupts their peace. The large envelope he was carrying earlier has been opened, revealing three large 8” x 10” landscape photos on the table top. Each one is a blown-up snapshot, slightly blurry like through another layer of glass, of an urban intersection and focused on the first car at the stoplight.
If Tim squints, turns the photograph sideways, and backs up a few feet—it wouldn’t be so obvious who was seated in the front. At that angle, though, he—
Dick snatches one of the photos off the table, puts his face right to the print, and pulls back to stare blankly at Tim. The lack of expressed anger is a warning sign; Cass abruptly gets up and moves to stand next to Babs’s wheelchair. Meanwhile, the older vigilante looks back and forth between Tim and Korvin, jaw tight as he’s working through some internal debate.
When Dick finally decides to fixate on Korvin, Tim can't explain the little bit of affront mixed in with his reflexive relief.
...
27 notes
·
View notes
omg iskra going back in time auau- but like- garak seeing two random cardassians on the station with no explanation why they r there, and they seem to know him like- what. Would they try to avoid him so he dont sus them out? what about names? They obviously cant say their surnames. And Ziyal 🥺 (sorry this is just such a edible idea anyway)
AWOOOOGH GARAK WOULD BE SO INTRIGUED! you KNOW he'd be hiding behind promenade pylons trying to get a drop on any information about the two cardassians that the captain has let stay on the station during the war against cardassia! You KNOWWW he'd be desperately trying to make eye contact with them at quark's! AND YOU KNOW ISKRA WOULD NOT BE ABLE TO RESIST THE TEMPTATION!
Unfortunately Idan is a first year starfleet student and like any student is deeply passionate about the letter and not the spirit of the law, and thinks that they should barricade themselves in their quarters so as to prevent temporal contradiction (as recommended in the textbook). Iskra, who graduated a cardassian jurisprudence apprenticeship and has a degree in comparative galactic law, recognizes that every set of regulations has loopholes just waiting to be tugged open and wiggled through. And that involves meeting all her aunts and uncles in their glory days, causing trouble, making cryptic remarks and flirting up a storm.
They probably do ask sisko to get bashir and garak off the station to minimize interference (Iskra also requests several other random crewmembers be kicked out. Just so that there's no implication about future events.) But not before she gets to meet her yadek! (and maybe get hit on by s3 era julian, eugh)
Iskra goes by her birth family name when she's not on Cardassia to minimize assassination attempts, so they're both Ghilanas (until SOMEONE hacks into the computer on their rented shuttle and finds their ID info...)
And also Ziyal... wary of two shiny young cardassians but still trying to put on a brave face...swept up by their openness and enthusiasm but deeply wary of the secret they seem to be hiding...
57 notes
·
View notes
"The Biden administration on Thursday [August 15, 2024] released prices for the first 10 prescription drugs that were subject to landmark negotiations between drugmakers and Medicare, a milestone in a controversial process that aims to make costly medications more affordable for older Americans.
The government estimates that the new negotiated prices for the medications will lead to around $6 billion in net savings for the Medicare program in 2026 alone when they officially go into effect, or 22% net savings overall. That is based on the estimated savings the prices would have produced if they were in effect in 2023, senior administration officials told reporters Wednesday.
The Biden administration also expects the new prices to save Medicare enrollees $1.5 billion in out-of-pocket costs in 2026 alone.
“For so many people, being able to afford these drugs will mean the difference between debilitating illness and living full lives,” Chiquita Brooks-LaSure, administrator for the Centers for Medicare & Medicaid Services, told reporters. “These negotiated prices. They’re not just about costs. They are about helping to make sure that your father, your grandfather or you can live longer, healthier.”
It comes one day before the second anniversary of President Joe Biden’s signature Inflation Reduction Act, which gave Medicare the power to directly hash out drug prices with manufacturers for the first time in the federal program’s nearly 60-year history.
Here are the negotiated prices for a 30-day supply of the 10 drugs, along with their list prices based on 2023 prescription fills, according to a Biden administration fact sheet Thursday.
What Medicare and beneficiaries pay for a drug is often much less than the list price, which is what a wholesaler, distributor or other direct purchaser paid a manufacturer for a medication before any discounts...
The administration unveiled the first set of medications selected for the price talks in August 2023, kicking off a nearly yearlong negotiation period that ended at the beginning of the month.
The final prices give drugmakers, which fiercely oppose the policy, a glimpse of how much revenue they could expect to lose over the next few years. It also sets a precedent for the additional rounds of Medicare drug price negotiations, which will kick off in 2025 and beyond.
First 10 drugs subject to Medicare price negotiations
Eliquis, made by Bristol Myers Squibb, is used to prevent blood clotting to reduce the risk of stroke.
Jardiance, made by Boehringer Ingelheim and Eli Lilly, is used to lower blood sugar for people with Type 2 diabetes.
Xarelto, made by Johnson & Johnson, is used to prevent blood clotting, to reduce the risk of stroke.
Januvia, made by Merck, is used to lower blood sugar for people with Type 2 diabetes.
Farxiga, made by AstraZeneca, is used to treat Type 2 diabetes, heart failure and chronic kidney disease.
Entresto, made by Novartis, is used to treat certain types of heart failure.
Enbrel, made by Amgen, is used to treat autoimmune diseases such as rheumatoid arthritis.
Imbruvica, made by AbbVie and J&J, is used to treat different types of blood cancers.
Stelara, made by Janssen, is used to treat autoimmune diseases such as Crohn’s disease.
Fiasp and NovoLog, insulins made by Novo Nordisk.
In a statement Thursday, Biden called the new negotiated prices a “historic milestone” made possible because of the Inflation Reduction Act. He specifically touted Vice President Kamala Harris’ tiebreaking vote for the law in the Senate in 2022.
Harris, the Democratic presidential nominee, said in a statement that she was proud to cast that deciding vote, adding there is more work to be done to lower health-care costs for Americans.
“Today’s announcement will be lifechanging for so many of our loved ones across the nation, and we are not stopping here,” Harris said in a statement Thursday, noting that additional prescription drugs will be selected for future rounds of negotiations."
-via CNBC, August 15, 2024
3K notes
·
View notes